Effect of Topical Brinzolamide on Visual Function in Infantile Nystagmus Syndrome
Key Findings
A randomized control trial evaluated the impact of topical brinzolamide on visual function and eye waveforms in infantile nystagmus syndrome (INS).
Highlights:
- Significant improvement in INS waveform characteristics and visual acuity with brinzolamide
- No significant change in head position and stereopsis
- No reported side effects with 3 months of brinzolamide therapy
Clinical Significance
Brinzolamide shows promise in improving visual acuity and INS waveforms in idiopathic INS, but further evidence is needed to determine its clinical significance.
Maximizing Clinical Trial Benefits in Everyday Practice
Clinical trials play a vital role in developing safe and effective treatments. It’s crucial to apply their benefits to routine medical practice.
Practical Solutions
- DocSym, an AI-driven platform, consolidates ICD-11 standards, clinical protocols, and research for easy access by clinicians.
- Mobile apps support scheduling, treatment monitoring, and telemedicine, streamlining operations and expanding digital services.
By leveraging AI, clinics can improve workflows, patient outcomes, and reduce paper-based routines. Learn more about our solutions at aidevmd.com.
